Long-term follow-up of phase II trial of docetaxel and cisplatin with concurrent thoracic radiation therapy for locally advanced non-small cell lung cancer

References

• Blackstock AW, Govindan R. Definitive chemoradiation for the treatment of locally advanced non small-cell lung cancer. J Clin Oncol 2007;25:4146–52.
   PubMedGoogle Scholar
• Kiura K, Ueoka H, Segawa Y, Tabata M, Kamei H, Takigawa N, . Phase I/II study of docetaxel and cisplatin with concurrent thoracic radiation therapy for locally advanced non-small-cell lung cancer. Br J Cancer 2003;89:795–802.
   PubMed Web of Science ®Google Scholar
• Segawa Y, Kiura K, Takigawa N, Kamei H, Harita S, Hiraki S, . Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007. J Clin Oncol 2010;28:3299–306.
   PubMed Web of Science ®Google Scholar
• Fournel P, Robinet G, Thomas P, Souquet PJ, Lena H, Vergnenegre A, . Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Francais de Pneumo-Cancerologie NPC 95-01 Study. J Clin Oncol 2005;23:5910–7.
   PubMed Web of Science ®Google Scholar
• Kubota K, Tamura T, Fukuoka M, Furuse K, Ikegami H, Ariyoshi Y, . Phase II study of concurrent chemotherapy and radiotherapy for unresectable stage III non-small-cell lung cancer: Long-term follow-up results. Japan Clinical Oncology Group Protocol 8902. Ann Oncol 2000;11:445–50.
   PubMedGoogle Scholar
• Kim DW, Shyr Y, Shaktour B, Akerley W, Johnson DH, Choy H. Long term follow up and analysis of long term survivors in patients treated with paclitaxel-based concurrent chemo/radiation therapy for locally advanced non-small cell lung cancer. Lung Cancer 2005;50:235–45.
   PubMedGoogle Scholar
• Keene KS, Harman EM, Knauf DG, McCarley D, Zlotecki RA. Five-year results of a phase II trial of hyperfractionated radiotherapy and concurrent daily cisplatin chemotherapy for stage III non-small-cell lung cancer. Am J Clin Oncol 2005;28:217–22.
   PubMedGoogle Scholar
• Auperin A, Le Pechoux C, Pignon JP, Koning C, Jeremic B, Clamon G, . Concomitant radio-chemotherapy based on platin compounds in patients with locally advanced non-small cell lung cancer (NSCLC): A meta-analysis of individual data from 1764 patients. Ann Oncol 2006;17:473–83.
   PubMed Web of Science ®Google Scholar
• Ohe Y, Ishizuka N, Tamura T, Sekine I, Nishiwaki Y, Saijo N. Long-term follow-up of patients with unresectable locally advanced non-small cell lung cancer treated with chemoradiotherapy: A retrospective analysis of the data from the Japan Clinical Oncology Group trials (JCOG0003A). Cancer Sci 2003;94:729–34.
   PubMedGoogle Scholar
• Takigawa N, Kiura K, Segawa Y, Watanabe Y, Kamei H, Moritaka T, . Second primary cancer in survivors following concurrent chemoradiation for locally advanced non-small-cell lung cancer. Br J Cancer 2006;95:1142–4.
   PubMedGoogle Scholar
• Chen AB, Neville BA, Sher DJ, Chen K, Schrag D. Survival outcomes after radiation therapy for stage III non-small-cell lung cancer after adoption of computed tomography-based simulation. J Clin Oncol 2011;29:2305–11.
   PubMedGoogle Scholar
• Senan S, Cardenal F, Vansteenkiste J, Stigt J, Akyol F, De Neve W, . A randomized phase II study comparing induction or consolidation chemotherapy with cisplatin-docetaxel, plus radical concurrent chemoradiotherapy with cisplatin-docetaxel, in patients with unresectable locally advanced non-small-cell lung cancer. Ann Oncol 2011;22:553–8.
   PubMed Web of Science ®Google Scholar
• Kocak M, Ozkan A, Mayadagli A, Parlak C, Bilici A, Seker M, . Induction chemotherapy and chemoradiation therapy for inoperable locally advanced non-small-cell lung cancer: A single-institution review of two different regimens. Clin Lung Cancer 2009;10:124–9.
   PubMedGoogle Scholar
• Chen Y, Pandya KJ, Hyrien O, Keng PC, Smudzin T, Anderson J, . Preclinical and pilot clinical studies of docetaxel chemoradiation for stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2010;80:1358–64.
   PubMedGoogle Scholar
• Machtay M, Bae K, Movsas B, Paulus R, Gore EM, Komaki R, . Higher biologically effective dose of radiotherapy is associated with improved outcomes for locally advanced non-small cell lung carcinoma treated with chemoradiation: An analysis of the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys Epub 2010 Oct 25.
   Google Scholar